Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

Novocure Ltd (NASDAQ:NVCR) shares soared sharply after the announcement that the FDA had approved Optune Lua, a wearable ...

ROOT, Switzerland, October 01, 2024--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) will report financial results for the third quarter 2024 on Wednesday, October 30, 2024, before the U.S. financial ...

The Vivint Smart Home security system is a full-blown home security system that gives you 24/7 monitoring and full control over door locks, cameras, thermostats, and lights. You can even monitor ...

Shares of Novocure were trading higher in Tuesday's late session after the company said that the Food and Drug Administration had approved Optune Lua, its wearable treatment for certain types of lung ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on NovoCure (NVCR – Research Report) today and set a price target of $28.00.

The digestive system is the series of tubelike organs that convert our meals into body fuel. There are about 30 feet (9 meters) of these convoluted pipeworks, starting with the mouth and ending ...

Oct. 15, 2024 — Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping tools. According to researchers who discovered this new ...

Successful expansion into these markets could substantially increase Novocure's patient base and revenue. The European market, with its diverse healthcare systems and large population, offers a vast ...

Novocure (NASDAQ: NVCR) will report financial results for the third quarter 2024 on Wednesday, October 30, 2024, before the U.S. financial markets open. Novocure management will host a conference ...